Clinical trials: Advanced Cancer Requiring Palliative Radiation
Cancer, Solid Tumor
Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients
This will be a multi-center, open-label, single-arm, prospective study, in which up to 18 adult patients requiring radiotherapy for metastatic disease or for an inoperable primary tumor with no definitive curative treatment…
- Conditions
- Cancer, Solid Tumor, Metastatic Disease
- Trial name
- NCT03823989
- Testing
- Promitil, EBR
- Where
- 3 sites in Israel
- Volunteers
- 18 people
- Sponsor
- Lipomedix Pharmaceuticals Inc.
Advanced Cancer Requiring Palliative Radiation
DART: Diagnostic-CT-Enabled Planning: A Randomized Trial in Palliative Radiation Therapy
The objective of this trial is to assess the efficacy, acceptability, and scalability of diagnostic-CT-enabled planning, compared to conventional CT simulation planning.
- Trial name
- DART (NCT05233904)
- Testing
- Diagnostic-CT-enabled Planning, Standard of Care
- Where
- Canada
- Volunteers
- 33 people
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Pancreatic Cancer
Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation
The purposes of this study are to: Evaluate the safety and toxicity of tolfenamic acid when used with gemcitabine and radiation therapy in patients with locally advanced or metastatic pancreatic cancer.
- Trial name
- NCT02159248
- Testing
- Tolfenamic acid + gemcitabine + radiation
- Where
- United States
- Sponsor
- Orlando Health, Inc.